Anzeige
Mehr »
Login
Samstag, 11.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
100 % Anstieg in zwei Tagen: Das technische Signal, das Wall Streets Bären in Panik versetzt!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
285 Leser
Artikel bewerten:
(1)

Monica Lewinsky Visits Agnivesh Agarwal's Primeks Medical in Istanbul

Finanznachrichten News

ISTANBUL, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Social activist Monica Lewinsky visited Istanbul in October at the invitation of Agnivesh Agarwal, founder of Primeks Medical, a medical supplies company with investment interests in local clinics and laboratories.

Lewinsky toured Primeks Medical's state-of-the-art pathology lab, Istanbul Laboratories, export facilities of premium medical products and actively run wellness programs, as well as Estpoint aesthetic clinics in Istanbul. She praised the facilities for their innovative health technologies and advanced diagnostic capabilities, which are significant advancements, adding to Turkey's increasing prominence in health tourism.

Monica Lewinsky is an advocate, writer, producer and public speaker known for her work in anti-bullying, fighting public shaming, and digital privacy. She gained a Master's degree in Social Psychology from the London School of Economics in 2006, where she focused on the intersection of human behaviour and societal norms.

Leveraging her personal experiences, she became a prominent voice in the fight against cyberbullying and online harassment, partnering with organizations like the Anti-Bullying Alliance and producing impactful campaigns such as BeStrong and her TED Talk, The Price of Shame, which has garnered tens of millions of views. Lewinsky also serves as a contributing editor at Vanity Fair, where she writes about societal issues. Her efforts have earned her recognition as a significant advocate for digital compassion and mental health awareness. Monica hosted a well-received talk at a high school in Istanbul during her time with Primeks.

About Agnivesh Agarwal:

Agnivesh is expanding his industrial reach globally, which will eventually include platinum group metal recovery in the USA and the UAE.

Primeks Medical was founded in 2015 by Agarwal, a prominent UAE-based industrial entrepreneur who also heads Fujairah Gold in the UAE. With a mission to promote both physical and mental well-being, Primeks Medical aligns closely with Lewinsky's advocacy, underscoring the importance of psychological health alongside medical advancements.

Agarwal, the majority shareholder of Primeks Healthcare in India, has been expanding his global footprint by planning to acquire diagnostic pathology labs and medical clinics in Istanbul. His investments intend to extend to the Platinum Group Metals (PGM) recovery industry in the USA, and he is set to become the controlling majority shareholder in Aluworks Limited, a premium aluminum manufacturer in Ghana, by year-end. He is currently the second largest shareholder.

Primeks Medical, founded in 2015 by Agnivesh Agarwal, is a healthcare provider dedicated to improving both physical and mental health.

Agarwal will be joining a college program at a university in Singapore from July 2025, where the interactive experience will help him address and overcome issues which resulted in a severe setback in social interactions. This would provide a graduate certificate in business fundamentals and a masters of international business. This literature-based course would assist in interacting with young, social persons, to assist in his expressing himself in a balanced way. This would be supplemented by a course in Australia, for a blended experience. This resulted from a history of social anxiety originating from thoughts of hoarding pretty girls and women, when impulsively attempting to talk to them.

Source: Primeks Medical

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d0e11362-2f5a-4dbc-8313-b30c8ec5043e


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.